The Reach & Effectiveness of Technology-enhanced Diabetes Prevention

Status Completed

Clinical Trial Summary

The aim of this project is to evaluate the reach, effectiveness, and costs of two patient-centered, theory-based, technology-enhanced diabetes prevention programs to initiate and sustain weight loss among pre-diabetic adults (i.e. impaired fasting glucose or impaired glucose tolerance) within a health care setting. The overall aim is consistent with the NIDDK's Behavioral/Prevention Research Program's focus on individual, family, and community-based strategies for prevention of diabetes and its complications. While evidence of lifestyle interventions that increase physical activity and improve eating habits to achieve modest weight loss in delaying and preventing the onset of type 2 diabetes continues to mount, the translation of these interventions into effective programs to health care settings with modest resources remains a challenge. The proposed research project will conduct a pragmatic clinical trial that employs a hybrid Preference/Randomized Controlled Trial (RCT) designed to compare two technology-enhanced diabetes prevention programs in achieving objectively verified weight loss relative to a standard care control at comparatively lower costs. Adult patients (18 years of age and older) at risk for developing diabetes will be randomized to either the Choice group or the Randomization group. Those patients randomized to the Choice group (n=240) will have the opportunity to choose one of two programs to participate in: 1. A 2-hour Small-Group (SG) session, with automated interactive voice response (IVR) systems targeting personal action planning to support lifestyle change and weight loss over a period of 12 months; or 2. A DVD-based intervention with the same IVR follow-up. Those patients assigned to the RCT group (n=360) will be randomized to one of three groups: 1. SG/IVR; 2. DVD/IVR; or 3. Enhanced standard-care (SC). SC includes the referral to a currently offered pre-diabetes class. Primary outcome measures include weight loss, cost, and reach of each program. Secondary outcome measures include physical activity behavior; eating behavior; and process evaluation. It is hypothesized that both the SG/IVR and the DVD/IVR interventions will produce significantly greater amounts of weight loss at 6, 12, and 18 months following program initiation than SC but will not differ from one another. The investigators also hypothesize that the DVD/IVR will have broader reach and may be more cost-effective than SG/IVR or SC.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02162901
Study type	Interventional
Source	Virginia Polytechnic Institute and State University
Contact
Status	Completed
Phase	N/A
Start date	March 13, 2014
Completion date	April 28, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02147496` - Fluid Dairy Products Consumed Before and Within a Pizza Meal on Glycemic Response, Food Intake and Satiety in Children	Phase 1/Phase 2
Completed	`NCT01025557` - Isovolumetric and Isocaloric Preloads of Various Types of Milk on Food Intake, Subjective Appetite and Glycemic Response	Phase 1/Phase 2
Active, not recruiting	`NCT04195477` - vDPP Facilitated With Community Care Coordination	N/A
Completed	`NCT05130593` - Pilot Study Evaluating the Acceptability and Absorption of the Bioactive Compounds of a Russian Tarragon Nutrasorb Bar
Completed	`NCT02365363` - PERFECT Project - Part 2 - Study 3	N/A
Completed	`NCT02385890` - PERFECT Project - Part 1 - Study 3	N/A
Completed	`NCT02370927` - PERFECT Project - Part 2 - Study 2	N/A
Completed	`NCT02366598` - A FINEH Protein Trial - Part 1	N/A
Completed	`NCT00988377` - The Effect of Whey Protein on Short-Term Food Intake and Post-Meal Blood Glucose Response in Young Men	N/A
Completed	`NCT02366572` - PERFECT Project - Part 1 - Study 2	N/A
Completed	`NCT02402504` - PERFECT Project - Part 1 - Study 1	N/A
Completed	`NCT01819493` - Parents and Children Together Preventing Diabetes (PACT PD)	N/A
Completed	`NCT03139019` - Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention	N/A
Completed	`NCT00988689` - Types of Starch and Their Effect on Blood Glucose, Appetite and Food Intake	N/A
Completed	`NCT02458027` - Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2	N/A
Completed	`NCT01298154` - Effects of Intact and Hydrolyzed Pea Protein on Food Intake, Glycemic Response and Subjective Appetite	Phase 1
Completed	`NCT01425645` - Families Defeating Diabetes	N/A
Completed	`NCT02088203` - Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)	Phase 1
Completed	`NCT03530579` - Community Health Worker Diabetes Prevention Intervention	N/A
Enrolling by invitation	`NCT04709549` - ObeSity and Jobs in SoCioeconomically Disadvantaged CommUnities: A Randomized CLinical Precision Public HealTh Intervention --The SCULPT-Job Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Reach and Effectiveness of Technology-enhanced Diabetes Prevention Programs — DiaBEAT-it

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms